Tibetan Medicines (tibetan + medicine)

Distribution by Scientific Domains


Selected Abstracts


The Sacred in the Scientific: Ambiguous Practices of Science in Tibetan Medicine

CULTURAL ANTHROPOLOGY, Issue 4 2001
Vincanne Adams
First page of article [source]


The Challenge of Cross-Cultural Clinical Trials Research: Case Report from the Tibetan Autonomous Region, People's Republic of China

MEDICAL ANTHROPOLOGY QUARTERLY, Issue 3 2005
VINCANNE ADAMS
Efforts to conduct Western clinical research in non-Western medical settings with little or no familiarity with such methodologies are on the rise, but documented accounts of the ways that biomedical science requires negotiation and translation across cultures are not plentiful. This article adds to this literature through analysis of an NICHD-funded collaborative research effort in women's health carried out in the Tibetan Autonomous Region of the People's Republic of China. The research involved a feasibility study for an eventual clinical trial comparing Tibetan medicine with misoprostol for preventing postpartum hemorrhage in delivering women. It explores strategies of negotiation and translation in and around notions of the scientific method, informed consent procedures, randomization, blinding, placebo, and concepts of medical standardization. [source]


Encouraging findings for Tibetan medicines in type 2 diabetes

FOCUS ON ALTERNATIVE AND COMPLEMENTARY THERAPIES AN EVIDENCE-BASED APPROACH, Issue 2 2001
Article first published online: 14 JUN 2010
[source]


Separation and determination of gentiopicroside and swertiamarin in Tibetan medicines by micellar electrokinetic electrophoresis

BIOMEDICAL CHROMATOGRAPHY, Issue 1 2004
Shengguo Zhao
Abstract Micellar electrokinetic electrophoresis was employed to determine two active components, gentiopicroside (GE) and swertiamarin (SW) in one Tibetan preparation medicine named shiweilongdankeli, two Tibetan herbal medicines named Gentiana rhodantha and Gentiana kitag and three other Chinese Gentiana medicines named Gentiana scabra, Gentiana rigescens and Gentiana macrophylla. The dissociation constants of gentiopicroside and swertiamarin determined by MEKC were 7.71 and 6.25. The optimum buffer system was 70 mm borate,10 mm sodium dodecylsulfate (SDS) ,6% (v/v) ispropanol (pH 9.0). The voltage was 15 kV and detection was at 254 nm. The lower limits of detection (de,ned as a signal-to-noise ratio of about 3) were approximately 3.86 mg L,1 for GE and 5.88 mg L,1 for SW. The relative standard deviation of the migration time and peak area of the GE and SW were 2.33, 2.47 and 1.27, 2.19%, respectively and the recoveries of the two compounds were 96,104% for GE and 92,102% for SW. Copyright © 2003 John Wiley & Sons, Ltd. [source]